Glycinergic transmission: physiological, developmental and pathological implications.

The last few years have seen remarkable developments in our understanding of the physiology, pharmacology and genetics of inhibitory glycinergic synapses. In part, this has been due to the development of new resources such as specific antisera recognizing glycine receptor (GlyR) and transporter (GlyT) subtypes, but also the characterization of new mouse, zebrafish and bovine genetic models of glycinergic dysfunction. What is also evident is the high quality and impact of the research conducted in this field. This is reflected in the reviews and research articles in this Special Issue entitled “Glycinergic transmission: physiological, developmental and pathological implications”